A recent Klimas/Broderick study had a lot of interesting things in it: the gender divide, and the illumination of possibly key immune and metabolic factors, but the most intriguing thing about the study was its potential precision.
The study possibly identified specific pathways associated with a powerful cytokine that could be tweaked with drugs to help people with ME/CFS. While much more study is needed, no one has developed this precise of an approach to treatment before. One hopes this is the future for ME/CFS.
Find out more in this Simmaron Research Foundation sponsored blog: